ctrl K

Price Alert

Arcus Biosciences Inc. (RCUS)

NYSE: RCUS · Real-Time Price · USD

10.37

0.46 (4.64%)

At close: Aug 15, 2025, 3:59 PM

10.40

0.29%

After-hours: Aug 15, 2025, 06:22 PM EDT

Arcus Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	150M	127M	206M	147.91M
Short-Term Investments	828M	632M	803M	351.39M
Long-Term Investments	14M	107M	129M	181.99M
Other Long-Term Assets	73M	106M	114M	591.19M
Receivables	25M	42M	43M	745M
Inventory	n/a	n/a	-172M	-762.44M
Other Current Assets	13M	30M	n/a	n/a
Total Current Assets	1.02B	831M	1.07B	681.3M
Property-Plant & Equipment	47M	51M	35M	137.42M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	134M	264M	278M	910.6M
Total Assets	1.15B	1.09B	1.34B	1.59B
Account Payables	18M	17M	20M	10.26M
Deferred Revenue	85M	91M	97M	102M
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	14M	39M	48M	5.08M
Total Current Liabilities	226M	184M	193M	166.08M
Long-Term Debt	48M	n/a	n/a	n/a
Other Long-Term Liabilities	391M	142M	140M	5.26M
Total Long-Term Liabilities	439M	449M	495M	584.36M
Total Liabilities	665M	633M	688M	750.45M
Total Debt	60M	11M	120M	116.89M
Common Stock	1.62B	1.31B	1.21B	7K
Retained Earnings	-1.13B	-849M	-542M	-275.35M
Comprehensive Income	n/a	n/a	-7M	-1.26M
Shareholders Equity	485M	462M	657M	841.45M
Total Investments	842M	739M	932M	533.38M